Animal studies have revealed no teratogenic, embryotoxic or fetotoxic effects. There are no controlled data in human pregnancy. AU...
Tag Archive for: HUMIRA
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) reported top-line results from a phase 3 trial involving their experimental drug sarilumab earlier...
AbbVie Receives Orphan Drug Designation for HUMIRA® (adalimumab) from the U.S. Food and Drug Administration for the Investigational Treatment...
“I WILL NOT HIDE” Hidradenitis suppurativa (HS) Patient Stories Book Series
The “I WILL NOT HIDE” Hidradenitis Suppurativa book series is now available. These patient story volumes tell the stories of Hidradenitis Suppurativa (HS) patients in vivid and personal narrative. Told by HS patients themselves.
HSAWARENESS EMAIL UPDATES
The Latest PUBMED Medical ResearchView All HS Research
- Acne inversa/hidradenitis suppurativa: An update November 20, 2017
- Correction to: Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa November 18, 2017
- Response to “IL-36 in hidradenitis suppurativa: Evidence for a distinctive pro-inflammatory role and a key factor in the development of an inflammatory loop” November 18, 2017
- Hidradenitis suppurativa-like lesions associated with pharmacologic inhibition of gamma-secretase November 11, 2017
- Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy November 11, 2017